Skip To Main Content
Pfizer will on Muck Rack

Pfizer will

As seen in: MarketScreener, AsiaNet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Pfizer will’s profile

Articles by Pfizer will

ARVINAS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) | MarketScreener

|
By with Pfizer, Pfizer will, As Defined, with Bayer AG
| MarketScreener
The following discussion and analysis is meant to provide material information relevant to an assessment of the financial condition and results of operations of our company, including an evaluation of the amount and certainty of cash flows from operations and from outside sources, so as to allow investors to better view our company from management's perspective.
Open in Who Shared Issue with article?

AsiaNet - View Release

|
By Pfizer will
| AsiaNet Verified
CStone and Pfizer announce NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer * The National Medical Products Administration approved sugemalimab for the treatment of patients with unresectable stage III non-small cell lung cancer whose disease has not progressed following concurrent or sequential platinum-based chemoradiotherapy * Sugemalimab became the first anti-PD-1/PD-L1 monoclonal antibody approved for stage III NSCLC following concurrent or...
Open in Who Shared View Duplicates (106) Issue with article?
Show More